331 related articles for article (PubMed ID: 19773637)
1. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up.
Mandal RV; Murali R; Lundquist KF; Ragsdale BD; Heenan P; McCarthy SW; Mihm MC; Scolyer RA; Zembowicz A
Am J Surg Pathol; 2009 Dec; 33(12):1778-82. PubMed ID: 19773637
[TBL] [Abstract][Full Text] [Related]
2. Two congenital cases of pigmented epithelioid melanocytoma studied by fluorescent in situ hybridization for melanocytic tumors: case reports and review of these recent topics.
Battistella M; Prochazkova-Carlotti M; Berrebi D; Bennaceur S; Edan C; Riffaud L; Rütten A; Fraitag S
Dermatology; 2010; 221(2):97-106. PubMed ID: 20558976
[TBL] [Abstract][Full Text] [Related]
3. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.
Zembowicz A; Carney JA; Mihm MC
Am J Surg Pathol; 2004 Jan; 28(1):31-40. PubMed ID: 14707861
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
5. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
6. Pigmented epithelioid melanocytoma (animal-type melanoma): An institutional experience.
Bax MJ; Brown MD; Rothberg PG; Laughlin TS; Scott GA
J Am Acad Dermatol; 2017 Aug; 77(2):328-332. PubMed ID: 28416343
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid and fusiform blue nevus of chronically sun-damaged skin, an entity distinct from the epithelioid blue nevus of the Carney complex.
Yazdan P; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2013 Jan; 37(1):81-8. PubMed ID: 22892599
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid sarcoma: Still an only surgically curable disease.
de Visscher SA; van Ginkel RJ; Wobbes T; Veth RP; Ten Heuvel SE; Suurmeijer AJ; Hoekstra HJ
Cancer; 2006 Aug; 107(3):606-12. PubMed ID: 16804932
[TBL] [Abstract][Full Text] [Related]
9. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
13. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
14. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
16. Cellular blue nevus (CBN) lymph node metastases of the neck with no primary skin lesion: a case report and review of literature.
Scheller K; Scheller C; Becker S; Holzhausen HJ; Schubert J
J Craniomaxillofac Surg; 2010 Dec; 38(8):601-4. PubMed ID: 20223677
[TBL] [Abstract][Full Text] [Related]
17. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
18. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols.
Argenziano G; Mordente I; Ferrara G; Sgambato A; Annese P; Zalaudek I
Br J Dermatol; 2008 Aug; 159(2):331-6. PubMed ID: 18510663
[TBL] [Abstract][Full Text] [Related]
19. So-called "malignant blue nevus": a clinicopathologic study of 23 patients.
Martin RC; Murali R; Scolyer RA; Fitzgerald P; Colman MH; Thompson JF
Cancer; 2009 Jul; 115(13):2949-55. PubMed ID: 19472395
[TBL] [Abstract][Full Text] [Related]
20. Pigmented epithelioid melanocytoma: report of a case with favourable outcome after a 4-year follow-up period.
Pepe CA; Lombardi M; Cortelazzi C; Aimi F; Ricci R; Taglia M; Santoro S; Zucchi A; Zambito-Spadaro F; De Panfilis G; Fabrizi G
Acta Biomed; 2014 May; 85(1):60-3. PubMed ID: 24897972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
